Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
- Authors: Provot O.1, Hamze A.1, Peyrat J.1, Brion J.1, Alami M.1
-
Affiliations:
- ,
- Issue: Vol 13, No 10 (2013)
- Pages: 1614-1635
- Section: Oncology
- URL: https://genescells.com/1871-5206/article/view/694869
- DOI: https://doi.org/10.2174/187152061310131206162302
- ID: 694869
Cite item
Full Text
Abstract
We have synthesized a large variety of CA-4 analogues having a non-isomerizable C-linker between the A- and B-aromatic rings. Most of them displayed a nanomolar level of cytotoxicity against a panel of human cancer cell lines and inhibited tubulin polymerization at a micromolar level. Among all these compounds, the most interesting compounds were undoubtedly isoCA-4 and structural analogues 18-20 as well as benzil derivatives 11 which displayed a comparable level of activity than that of CA-4. Moreover, it has been demonstrated that these drugs arrested cancer cells in the G2/M phase of cellular cycle and induced apoptosis at very low concentrations. In vitro antivascular effects and the binding mode of the most active compounds was also investigated.
Keywords
About the authors
Olivier Provot
,
Email: info@benthamscience.net
Abdallah Hamze
,
Email: info@benthamscience.net
Jean-François Peyrat
,
Email: info@benthamscience.net
Jean-Daniel Brion
,
Email: info@benthamscience.net
Mouad Alami
,
Email: info@benthamscience.net
Supplementary files
